Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iovance Biotherapeutics Inc (NQ: IOVA )

10.59 -1.69 (-13.80%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics Inc

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another breakdown of the biggest pre-market stock movers as we check out all of the shares rising and falling on Tuesday! 
Via InvestorPlace
JetBlue Airways, VOXX International And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
WD-40, VOXX International And 3 Stocks To Watch Heading Into Tuesday
With U.S. stock futures trading slightly higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Iovance Biotherapeutics, Inc. Announces Pricing of Its Public Offering of $150 Million of Common Stock
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Analyst Ratings for Iovance Biotherapeutics
Via Benzinga
Analyst Expectations for Iovance Biotherapeutics's Future
Via Benzinga
Fisker, Iovance Biotherapeutics Lead Gains — Tesla Dips: Top 5 Trending Stocks Today
Via Benzinga
Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Iovance's Update Provides Reassurance With Upcoming Lifileucel's FDA Action Date, Analyst Says
Iovance Biotherapeutics Inc (NASDAQ: IOVA) announced regulatory and clinical updates related to its registrational single-arm Phase 2 IOV-LUN-202 trial in post-anti-PD-1  
Via Benzinga
Why Iovance Biotherapeutics (IOVA) Shares Are Exploding Higher
Iovance Biotherapeutics Inc (NASDAQ: IOVA) shares are trading higher by 14.3% to $8.28 Monday morning after the company announced regulatory, clinical updates for TIL therapy in 
Via Benzinga
Iovance Biotherapeutics Announces Regulatory and Clinical Updates for TIL Therapy in Advanced Non-Small Cell Lung Cancer
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
What's Going On With Iovance Biotherapeutics Stock?
Iovance Biotherapeutics Inc (NASDAQ: IOVA) shares are trading higher Tuesday after the U.S. 
Via Benzinga
Where Iovance Biotherapeutics Stands With Analysts
Via Benzinga
Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Mobilicom Limited (NASDAQ: MOB) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Iovance Biotherapeutics to Host Virtual Roundtable with Key Opinion Leaders to Discuss Melanoma Treatment Landscape
Investor Conference Call and Webcast on June 26 at 5:00 p.m. ET 
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Analyst Ratings for Iovance Biotherapeutics
Via Benzinga
Recap: Iovance Biotherapeutics Q1 Earnings
Via Benzinga
How to Trade Stocks Online the Right Way
Learning how active trading works requires serious education, including learning how to get started. Learn how to trade stocks online on MarketBeat. 
Via MarketBeat
Iovance Biotherapeutics to Present at Jefferies Global Healthcare Conference
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Biotech Alert: Searches Spiking For These Stocks Today - Friday, June 2
Various names in the biotech sector are seeing a substantial increase in search activity today. Such names include the likes of Akebia Therapeautics, Corvus Pharmaceuticals, and Mirati Therapeutics. 
Via Talk Markets
Why Shares of Iovance Biotherapeutics Jumped Tuesday
The company received approval for a biologics license application for an advanced melanoma therapy. 
Via The Motley Fool
Iovance Biotherapeutics Spikes on Melanoma BLA FDA Application
Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares spiked over 20% on its advanced-stage melanoma treatment application to the U.S. Food and Drug Admin 
Via MarketBeat
Topics Death
Exposures Death Product Safety
Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving Premarket
Gainers QualTek Services Inc. (NASDAQ: QTEK) shares rose 206.7% to $0.2350 in pre-market trading after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter... 
Via Benzinga
Gaotu Techedu, Iovance Biotherapeutics And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Gaotu Techedu Inc. (NYSE: GOTU) shares jumped 19.7% to $2.98 in pre-market... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Ulta Beauty, Tilray Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.